| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.32 | 1e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 2e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |